EDUARDO
DÍAZ-RUBIO GARCÍA
Investigador hasta 2020
Dana–Farber Cancer Institute
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (6)
2024
-
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis
European Journal of Cancer, Vol. 207
2019
-
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer
JAMA network open, Vol. 2, Núm. 9, pp. e1911750
2017
-
Clinical calculator for Early mortality in Metastatic colorectal cancer: An analysis of Patients from 28 clinical trials in the aide et recherche en cancérologie digestive database
Journal of Clinical Oncology, Vol. 35, Núm. 17, pp. 1929-1937
-
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials
Annals of Oncology, Vol. 28, Núm. 9, pp. 2077-2085
2016
-
Body mass index is prognostic in metastatic colorectal cancer: Pooled analysis of patients from first-line clinical trials in the ARCAD database
Journal of Clinical Oncology, Vol. 34, Núm. 2, pp. 144-150
2015
-
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: Findings from the analysis and research in cancers of the digestive system database
Journal of Clinical Oncology, Vol. 33, Núm. 1, pp. 22-28